Edition:
United States

Amedica Corp (AMDA.OQ)

AMDA.OQ on NASDAQ Stock Exchange Capital Market

2.97USD
9:46am EST
Change (% chg)

$0.03 (+1.02%)
Prev Close
$2.94
Open
$2.95
Day's High
$2.99
Day's Low
$2.95
Volume
484
Avg. Vol
11,780
52-wk High
$8.86
52-wk Low
$2.91

Latest Key Developments (Source: Significant Developments)

Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen
Monday, 6 Nov 2017 09:00am EST 

Nov 6 (Reuters) - Amedica Corp :Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen.  Full Article

AMEDICA ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS
Tuesday, 3 Oct 2017 10:25am EDT 

Oct 3 (Reuters) - Amedica Corp ::AMEDICA ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS.‍SPECIAL MEETING WILL RECONVENE AT 9:00 A.M. LOCAL TIME ON OCTOBER 10, 2017​.ADJOURNMENT IS TO ALLOW FOR SOLICITATION OF ADDITIONAL VOTES IN FAVOR OF PROPOSAL CONTAINED IN DEFINITIVE PROXY STATEMENT FILED ON JULY 28​.‍ADJOURNMENT IS TO ALLOW FOR SOLICITATION OF VOTES IN FAVOR OF PROPOSAL CONTAINED IN DEFINITIVE PROXY STATEMENT REGARDING REVERSE SPLIT OF STOCK​.  Full Article

Amedica Corp says preliminary unaudited GAAP net loss for Q1 was $0.07 per share
Friday, 22 Sep 2017 09:00am EDT 

Sept 22 (Reuters) - Amedica Corp :Amedica Corp - ‍preliminary unaudited revenue of $2.6 million for Q1 of 2017 as compared to revenue of $4.2 million for Q1 of 2016​.Amedica Corp - preliminary unaudited GAAP net loss for Q1 of 2017 was $0.07 per share.Amedica Corp - Amedica reported preliminary unaudited revenue of $3.2 million for Q2 of 2017 as compared to revenue of $4.0 million for Q2 of 2016.Amedica Corp - ‍preliminary unaudited GAAP net loss for Q2 of 2017 was $0.05 per share​.Amedica Corp - remains on track to file 510k submission with modified porous cervical implant in Oct 2017 based on FDA feedback​.  Full Article

Amedica Q4 GAAP loss per share $0.16
Thursday, 8 Jun 2017 09:00am EDT 

June 8 (Reuters) - Amedica Corp ::Q4 preliminary GAAP loss per share $0.16.Q4 revenue $3.6 million.Amedica Corp says preliminary revenue of $3.6 million for Q4 of 2016.  Full Article

Amedica announces delayed filing of quarterly report on form 10-Q
Friday, 26 May 2017 09:00am EDT 

May 26 (Reuters) - Amedica Corp : :Amedica announces delayed filing of quarterly report on form 10-Q and receipt of nasdaq letter.Amedica Corp- delayed filing of its quarterly report on form 10-Q for quarter ended March 31, 2017.  Full Article

Amedica announces regulatory clearance to market and sell Valeo in Australia
Monday, 24 Apr 2017 07:00am EDT 

April 24 (Reuters) - Amedica Corp :Amedica announces regulatory clearance to market and sell Valeo silicon nitride spinal implants in Australia.Amedica Corp - granted marketing clearance for its Valeo interbody fusion devices in Australia.  Full Article

Amedica concludes unaudited condensed financials
Wednesday, 19 Apr 2017 06:22am EDT 

April 19 (Reuters) - Amedica Corp ::Amedica - on April 13 concluded unaudited condensed financials filed on Nov. 14, 2016 for quarter ended Sept. 30, 2016 should no longer be relied upon.Amedica - while preparation of financials for FY ended Dec. 31, 2016, identified errors due to failure to record one-time non-cash charge of $3.8 million.Amedica Corp says one-time non-cash charge was for deemed dividend related to accretion of a discount on conversion of series a preferred stock.Amedica Corp says increase in deemed dividend went from a previously reported amount $2.5 million to $6.3 million, an increase of $3.8 million.Amedica - the adjustment causes an increase in per share net loss to common stockholders for three month period ended Sept. 30, 2016 from $0.30 to $0.46.Amedica - the adjustment will also increase per share net loss to common stockholders for 9-month period ended Sept. 30, 2016 from $0.97 to $1.21- SEC filing.  Full Article

Amedica announces proposed public offering of common stock and warrants
Wednesday, 18 Jan 2017 04:01pm EST 

Amedica Corp - : Amedica announces proposed public offering of common stock and warrants .Net proceeds from offering will be used by amedica to remain in compliance with financial covenants in outstanding loan, security agreement.  Full Article

Amedica reports new sales leadership and provides regulatory updates
Tuesday, 22 Nov 2016 09:20am EST 

Amedica Corp : FDA also notified company that new pedicle screw system, taurus, has been cleared for commercialization . Amedica Corp - has been notified that fda did not clear its 510(k) premarket application to commercialize valeo c+csc . Amedica Corp - company is on target for surgical implantation and a full market launch of taurus system by end of year . Amedica Corp - working with fda to examine other pathways to introduce valeo c+csc technology to U.S. Market .Amedica announces new sales leadership and provides regulatory updates.  Full Article

Amedica announces workforce reduction by about 38 pct
Wednesday, 5 Oct 2016 09:15am EDT 

Amedica Corp : Amedica announces workforce reduction . Reduced its workforce by approximately 38% to lower its operating expenses . Reduced its workforce by approximately 38% . Actions associated with plan were implemented on october 3, 2016 and completed on october 4, 2016 .Estimates staff reductions to result in savings of approximately $2.0 million in cash operating expenses.  Full Article

BRIEF-Amedica announces reverse stock split

* Amedica Corp - ‍announced a 1-for-12 reverse stock split of its issued and outstanding common stock​ Source text for Eikon: Further company coverage: